000			01175 a2200337 4500
005			20250513022941.0
264		0	_c19800825
008			198008s 0 0 eng d
022			_a0361-5952
040			_aNLM _beng _cNLM
100	1		_aBerstock, D A
245	0	0	_aImproved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis. _h[electronic resource]
260			_bAdvances in prostaglandin and thromboxane research _c1980
300			_a567-9 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAnimals
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aFemale
650	0	4	_aFlurbiprofen _xtherapeutic use
650	0	4	_aMammary Neoplasms, Experimental _xdrug therapy
650	0	4	_aMelphalan _xtherapeutic use
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMice
650	0	4	_aNeoplasm Recurrence, Local
650	0	4	_aPropionates _xtherapeutic use
650	0	4	_aProstaglandin Antagonists
700	1		_aHoughton, J
700	1		_aBennett, A
773	0		_tAdvances in prostaglandin and thromboxane research _gvol. 6 _gp. 567-9
999			_c7385798 _d7385798